Serina Therapeutics, Inc.

Serina Therapeutics, Inc. company information, Employees & Contact Information

Serina Therapeutics is a privately held biotechnology company located in Huntsville, Alabama. We have developed a proprietary, clinically-validated polymer technology based on the water-soluble polymer poly(oxazoline). We call it POZ for short. Please visit our website at www.serinatherapeutics.com and review the exciting work we are doing in vaccines, Parkinson's disease, pain, oncology and cannabinoid science.

Company Details

Employees
20
Founded
-
Address
601 Genome Way, Huntsville,alabama 35806,united States
Phone
256-327-0566
Email
in****@****ics.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Huntsville, Alabama
Looking for a particular Serina Therapeutics, Inc. employee's phone or email?

Serina Therapeutics, Inc. Questions

News

Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Disease - Sahm

Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Disease Sahm

Serina Therapeutics Announces FDA Feedback Supports Registrational Trial Design of SER-252 in Advanced Parkinson’s Disease under 505(b)(2) NDA Pathway - GlobeNewswire

Serina Therapeutics Announces FDA Feedback Supports Registrational Trial Design of SER-252 in Advanced Parkinson’s Disease under 505(b)(2) NDA Pathway GlobeNewswire

$5M tranche: Serina advances SER-252—IND filed, HREC approval; global registrational trial to start Q4 2025 - Stock Titan

$5M tranche: Serina advances SER-252—IND filed, HREC approval; global registrational trial to start Q4 2025 Stock Titan

Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference - Yahoo Finance

Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference Yahoo Finance

Serina Therapeutics Congratulates Juvenescence on Securing $150 Million Series B Financing and Strategic Alliance with M42 - Nasdaq

Serina Therapeutics Congratulates Juvenescence on Securing $150 Million Series B Financing and Strategic Alliance with M42 Nasdaq

Serina Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights - GlobeNewswire

Serina Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights GlobeNewswire

Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42 - Yahoo Finance

Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42 Yahoo Finance

Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference - Stock Titan

Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference Stock Titan

Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors - Sahm

Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors Sahm

Parkinson's Drug Developer Serina Therapeutics Awards 12,500 Stock Options to Key New Hire - Stock Titan

Parkinson's Drug Developer Serina Therapeutics Awards 12,500 Stock Options to Key New Hire Stock Titan

Serina Therapeutics Launches Enhanced Corporate Communications Platform to Strengthen Engagement With Patients, Clinicians, and Investors - 富途牛牛

Serina Therapeutics Launches Enhanced Corporate Communications Platform to Strengthen Engagement With Patients, Clinicians, and Investors 富途牛牛

Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights - GlobeNewswire

Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights GlobeNewswire

$20M Funding Powers Breakthrough: Serina's Novel Parkinson's Drug Heads to Registrational Trial for 180K Patients - Stock Titan

$20M Funding Powers Breakthrough: Serina's Novel Parkinson's Drug Heads to Registrational Trial for 180K Patients Stock Titan

FDA Supports Fast-Track 505(b)(2) Path for Serina's Novel Parkinson's Drug SER-252 for Motor Control - Stock Titan

FDA Supports Fast-Track 505(b)(2) Path for Serina's Novel Parkinson's Drug SER-252 for Motor Control Stock Titan

Serina Therapeutics Secures Up to $20 Million to Advance Registrational Trial of SER-252 in Parkinson’s Disease - GlobeNewswire

Serina Therapeutics Secures Up to $20 Million to Advance Registrational Trial of SER-252 in Parkinson’s Disease GlobeNewswire

Serina Therapeutics CSO Moreadith sells $32,286 in stock - Investing.com

Serina Therapeutics CSO Moreadith sells $32,286 in stock Investing.com

Serina Therapeutics stock soars after FDA feedback on Parkinson’s drug - Investing.com

Serina Therapeutics stock soars after FDA feedback on Parkinson’s drug Investing.com

Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics - Yahoo Finance

Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics Yahoo Finance

Serina Therapeutics Secures $5M for Parkinson’s Trial - TipRanks

Serina Therapeutics Secures $5M for Parkinson’s Trial TipRanks

Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman - GlobeNewswire

Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman GlobeNewswire

Serina Therapeutics Stock (SER) Soars 20% on FDA Support - TipRanks

Serina Therapeutics Stock (SER) Soars 20% on FDA Support TipRanks

Serina Therapeutics And AgeX Therapeutics To Merge - citybiz

Serina Therapeutics And AgeX Therapeutics To Merge citybiz

Serina Therapeutics CSO sells $27,274 in stock - Investing.com

Serina Therapeutics CSO sells $27,274 in stock Investing.com

Why Did Serina Therapeutics Stock Rocket 37% After The Bell Today? - Stocktwits

Why Did Serina Therapeutics Stock Rocket 37% After The Bell Today? Stocktwits

Serina Therapeutics Secures $20M for Parkinson’s Trial - TipRanks

Serina Therapeutics Secures $20M for Parkinson’s Trial TipRanks

Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement - Business Wire

Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement Business Wire

Serina Therapeutics says submits IND to FDA, receives HREC approval in Australia for SER-252 - SEC filing - MarketScreener

Serina Therapeutics says submits IND to FDA, receives HREC approval in Australia for SER-252 - SEC filing MarketScreener

Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket - Benzinga

Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket Benzinga

Serina Therapeutics to merge with subsidiary of AgeX - Pharmaceutical Technology

Serina Therapeutics to merge with subsidiary of AgeX Pharmaceutical Technology

Serina Therapeutics Stock Soars Pre-Market On $10M Equity Deal To Fund Parkinson’s Trials: Retail Sentiment Explodes - Stocktwits

Serina Therapeutics Stock Soars Pre-Market On $10M Equity Deal To Fund Parkinson’s Trials: Retail Sentiment Explodes Stocktwits

SER - Serina Therapeutics Latest Stock News & Market Updates - Stock Titan

SER - Serina Therapeutics Latest Stock News & Market Updates Stock Titan

Serina Therapeutics receives state grant to develop pain drug, target opioid misuse and addiction - Huntsville Business Journal

Serina Therapeutics receives state grant to develop pain drug, target opioid misuse and addiction Huntsville Business Journal

Top Serina Therapeutics, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant